Effect of ridogrel, a combined thromboxane A2 synthase inhibitor/ prostaglandin endoperoxide receptor antagonist, on the lysis of platelet-rich coronary arterial thrombi with recombinant tissue-type plasminogen activator in a canine model

Prostaglandin Endoperoxide ◽

Type Plasminogen Activator ◽

Synthase Inhibitor

Evaluation of combination of tissue type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a middle cerebral artery thrombosis model in rats.

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)39692-1 ◽

1993 ◽

Vol 61 ◽

pp. 318

Author(s):

Kazuo Umemura ◽

Koichiro Wada ◽

Masayuki Ishiye ◽

Yoshinori Toshima ◽

Toshihiko Uematsu ◽

...

Keyword(s):

Middle Cerebral Artery ◽

Receptor Antagonist ◽

Plasminogen Activator ◽

Thromboxane A2 ◽

Tissue Type ◽

Thromboxane A2 Receptor ◽

Thrombosis Model ◽

Artery Thrombosis ◽

Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model.

Stroke ◽

10.1161/01.str.24.7.1077 ◽

1993 ◽

Vol 24 (7) ◽

pp. 1077-1081 ◽

Cited By ~ 80

Author(s):

K Umemura ◽

K Wada ◽

T Uematsu ◽

M Nakashima

Keyword(s):

Middle Cerebral Artery ◽

Receptor Antagonist ◽

Plasminogen Activator ◽

Thromboxane A2 ◽

Tissue Type ◽

Thromboxane A2 Receptor ◽

Thrombosis Model ◽

Artery Thrombosis ◽

Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.

Circulation ◽

10.1161/01.cir.79.4.911 ◽

1989 ◽

Vol 79 (4) ◽

pp. 911-919 ◽

Cited By ~ 59

Author(s):

P Golino ◽

J H Ashton ◽

J McNatt ◽

P Glas-Greenwalt ◽

S K Yao ◽

...

Keyword(s):

Plasminogen Activator ◽

Coronary Thrombosis ◽

Thromboxane A2 ◽

Canine Model ◽

Tissue Type ◽

Simultaneous Administration ◽

Receptor Antagonists ◽

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.

Circulation ◽

10.1161/01.cir.81.2.617 ◽

1990 ◽

Vol 81 (2) ◽

pp. 617-627 ◽

Cited By ~ 57

Author(s):

J K Mickelson ◽

P J Simpson ◽

M Cronin ◽

J W Homeister ◽

E Laywell ◽

...

Keyword(s):

Coronary Artery ◽

Plasminogen Activator ◽

Canine Model ◽

Tissue Type ◽

Antiplatelet Antibody ◽

Effect of ridogrel on the lysis of platelet-rich coronary artery thrombi with recombinant tissue-type plasminogen activator in a canine model

Journal of Molecular and Cellular Cardiology ◽

10.1016/0022-2828(90)91729-q ◽

1990 ◽

Vol 22 ◽

pp. S68

Author(s):

H.R. Lu ◽

M. Masuda ◽

F. De Clerk ◽

W. Flameng ◽

D. Collen

Keyword(s):

Coronary Artery ◽

Plasminogen Activator ◽

Canine Model ◽

Tissue Type ◽

Comparative Study of a Mutant Tissue-type Plasminogen Activator, YM866, with a Tissue-type Plasminogen Activator in a Canine Model of Femoral Arterial Thrombosis

Journal of Pharmacy and Pharmacology ◽

10.1111/j.2042-7158.1996.tb05897.x ◽

1996 ◽

Vol 48 (10) ◽

pp. 1041-1048 ◽

Cited By ~ 1

Author(s):

T. Kawasaki ◽

S. Kaku ◽

Y. Sakai ◽

T. Takenaka

Keyword(s):

Comparative Study ◽

Plasminogen Activator ◽

Arterial Thrombosis ◽

Canine Model ◽

Tissue Type ◽

Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation.

Circulation ◽

10.1161/01.cir.83.3.1038 ◽

1991 ◽

Vol 83 (3) ◽

pp. 1038-1047 ◽

Cited By ~ 61

Author(s):

T Yasuda ◽

H K Gold ◽

R C Leinbach ◽

H Yaoita ◽

J T Fallon ◽

...

Keyword(s):

Receptor Antagonist ◽

Plasminogen Activator ◽

Tissue Type ◽

Type Plasminogen Activator ◽

Arterial Thrombolysis

Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.

Circulation Research ◽

10.1161/01.res.65.1.83 ◽

1989 ◽

Vol 65 (1) ◽

pp. 83-94 ◽

Cited By ~ 108

Author(s):

D J Fitzgerald ◽

F Wright ◽

G A FitzGerald

Keyword(s):

Plasminogen Activator ◽

Platelet Activation ◽

Thromboxane A2 ◽

Tissue Type ◽

Coronary Thrombolysis ◽

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.86.19.7585 ◽

1989 ◽

Vol 86 (19) ◽

pp. 7585-7589 ◽

Cited By ~ 112

Author(s):

D. J. Fitzgerald ◽

G. A. Fitzgerald

Keyword(s):

Plasminogen Activator ◽

Thromboxane A2 ◽

Tissue Type ◽

Coronary Thrombolysis ◽

The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator

American Heart Journal ◽

10.1016/0002-8703(91)90708-p ◽

1991 ◽

Vol 121 (2) ◽

pp. 426-433 ◽

Cited By ~ 5

Author(s):

Gary J. Grover ◽

Charles S. Parham ◽

William A. Schumacher

Keyword(s):

Receptor Antagonist ◽

Plasminogen Activator ◽

Tissue Type ◽

Thromboxane Receptor ◽

Type Plasminogen Activator ◽

Thromboxane Receptor Antagonist